A Potential New Treatment for Patients With ALS is on the Horizon
Tikomed's ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in ALS patients. A myotrophic lateral sclerosis (ALS) is a lethal...